Santa Farma, which was incorporated in 1944 as a privately-owned pharmaceutical company, celebrates its 75th anniversary in pharma industry.  Within the framework of successful business results since its establishment, Santa Farma ranks among the leading pharmaceutical companies in Turkey with an annual turnover of 100 million USD.

Aiming to become a local and global contract manufacturing hub for internationally renowned companies, Santa Farma adopted modern production techniques in its brand-new, state-of-the-art manufacturing facility, which is EU-GMP certified. This modern facility has a capacity of 150 million units/shift and the ability to produce solids, semi solids, effervescent tablets and liquids, including a number of specialized forms, such as sachets, pellets, tab-in-caps and bilayer tablets.

Santa Farma currently offers products developed in its R&D center and manufactured in its premises in 10 different therapeutic categories both in local market and in 45 countries in CIS, Asia, Sub-Saharan Africa and Latin America.

Following cooperation models are offered by Santa Farma:
o   Supplying Finished dosage form using distributorship model or private labelling
o   Technology transfer
o   Contract manufacturing
o   Co-development / Contract development

Related Categories

Sales Markets

Middle East Region (e.g. UAE); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)